On the one hand these discoveries are good for the drug companies. They get to make money from an unexpected revenue source. And, I hope, some of the profit goes back into research. As for profit, it appears that they are charging about $50 more for a smaller dose. So the people who feel that they have inadequate eyelashes are making the manufacturer, Allergan, very happy.